Phase 3 Study of KW-6500 (Safety Study for Long-Term Self-Administration at Home in Patients With Parkinson's Disease).
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 15 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2010 Changed actual initiation date from 1 Jul 2009 to 1 Oct 2009, according to a Kyowa Hakko Kirin media release.
- 18 Aug 2009 New trial record